SixPex LabsTirzepatide 10 Mg
| Quantity | Discount | Price |
|---|---|---|
| 3–5 | 10% | $135,00 |
| 6–9 | 15% | $127,50 |
| 10–100 | 20% | $120,00 |
Specifications
- Brand: SixPex Labs Peptides & SARMs
- Substance: Tirzepatide
- Product Form: Powder
- Dosage: 10 Mg
How To Use
Laboratory Preparation & Research Dosing Protocols
Disclaimer: The following information is for educational and laboratory reference only. This product is strictly for in-vitro and in-vivo research and is not intended for human consumption or therapeutic use.
This vial contains 10 mg (10,000 mcg) of lyophilized Tirzepatide powder. Careful handling and precision measurement are critical for accurate data collection.
Reconstitution Guide
For standard research concentration, reconstitute the 10 mg vial with 1 ml or 2 ml of Bacteriostatic Water. (Using 2 ml provides greater measuring precision).
- Preparation: Slowly inject the water against the glass wall of the vial.
- Dissolution: Swirl gently until clear. Do not shake, as the peptide structure is sensitive to mechanical stress.
- Measurement Reference (Using 2 ml dilution):
- 4 Units (0.04 ml) = 200 mcg
- 10 Units (0.10 ml) = 500 mcg
- 20 Units (0.20 ml) = 1,000 mcg (1 mg)
Storage Specifications
- Unmixed (Lyophilized): Store in a cool, dry place. For long-term preservation, store at -20°C.
- Mixed (Reconstituted): Must be refrigerated (2°C to 8°C). Use within 14-21 days for maximum analytical integrity.
Experience Level Usage Guide
Beginner
Baseline Metabolic Secretagogue Model
Reference dosing for initial studies investigating the modulation of basal metabolic rate and early tolerance.
- Test Subject Dosage: 200 mcg to 500 mcg per administration.
- Frequency: Administered as a single dose once weekly.
- Research Aim: Assessment of subject tolerance and appetite regulation markers.
Intermediate
Advanced Thermogenic Evaluation Model
Standard dosage for evaluating the long-term impact of dual-pathway agonism on weight loss.
- Test Subject Dosage: 500 mcg to 1,000 mcg (1 mg) per week (can be split into smaller sub-doses, e.g., 500 mcg twice a week).
- Frequency: Administered on a weekly basis, or split into two smaller administrations.
- Observation Period: 4 to 8 weeks for longitudinal data collection.
Advanced
The Metabolic Synergy Stack
Advanced protocol investigating the synergy between fat oxidation and direct tissue remodeling.
- The Stack: Tirzepatide (500 mcg weekly) + BPC-157 (250 mcg daily).
- Scientific Rationale: Investigates the combined impact of profound energy expenditure/fat loss (Tirzepatide) alongside systemic soft-tissue/cytoprotective repair (BPC-157).
- Frequency: Combined weekly and daily schedule according to study objectives.
Shipping Details
Detailed Description
What Is SixPex Labs Tirzepatide 10 mg?
SixPex Labs Tirzepatide 10 mg is an innovative, dual-action incretin mimetic compound. It functions as a highly synergistic combined Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-1 (GLP-1) receptor agonist. In the scientific community, it is extensively researched for its profound ability to activate both pathways simultaneously, resulting in unparalleled metabolic regulation, deep fat utilization, and stabilized glycemic balance. This 10 mg lyophilized preparation is an ideal instrument for high-precision USA domestic research facilities investigating advanced weight management protocols and lipid clearance mechanisms over extended periods.
If your research goals involve exploring advanced glycemic balance or executing complex body recomposition assays, you can buy peptides of this analytical grade through our Fat Loss Peptides category.
Important: SixPex Labs Tirzepatide 10 mg is strictly for laboratory research and is not intended for human consumption or therapeutic use.
SixPex Labs Tirzepatide 10 mg: Technical Profile
| Scientific Parameter | Details for SixPex Labs Tirzepatide |
|---|---|
| Peptide Category | Dual GIP and GLP-1 Receptor Agonist |
| Vial Concentration | 10 mg Lyophilized Powder |
| Mechanism Focus | Glycemic Index Regulation, Satiety Signaling & Lipid Clearance |
Research Benefits of SixPex Labs Tirzepatide 10 mg
In controlled laboratory settings, it is valued for its multi-layered metabolic effects. Key research benefits include:
- Dual-Receptor Synergy: Studying the compound’s combined action on both GIP and GLP-1 receptors to optimize lipid clearance and drastically improve insulin sensitivity beyond single-pathway agents.
- Appetite and Craving Suppression: Investigating its action on the hypothalamus and brainstem, effectively influencing the neurological centers that control hunger and gastric emptying.
- Improved Glycemic Control: Researching the peptide’s ability to blunt sharp post-meal glucose spikes, lower fasting blood sugar, and improve overall metabolic efficiency.
- Synergy with Metabolic Agents: Exploring how Peptidesline’s Tirzepatide interacts with localized secretagogues to create a well-rounded approach to experimental weight-loss modeling.
How Does SixPex Labs Tirzepatide 10 mg Work?
The mechanism of Tirzepatide relies on its ability to mimic both GIP and GLP-1 incretin hormones simultaneously. It acts centrally on the brain to powerfully increase feelings of satiety and decrease overall food intake, while working peripherally to stimulate glucose-dependent insulin secretion and lower detrimental glucagon levels. Because Peptidesline provides vacuum-sealed, analytical-grade SixPex Labs products, researchers can reliably track these physiological shifts with high experimental accuracy.
Potential Side Effects in Research Models
Researchers utilizing Tirzepatide must monitor for physiological responses associated with its administration:
- Gastrointestinal Distress: Potential observed effects include temporary nausea or vomiting during initial exposure as gastric emptying significantly slows.
- Localized Sensitivity: Possible mild redness, warmth, or irritation at the subcutaneous injection site.
- Metabolic Variation: Fluctuations in baseline glucose markers that require close monitoring in test subjects to prevent deep hypoglycemic dips.
- Cardiovascular Changes: Possible observed increases in resting heart rate during early-stage, high-concentration assays.
Tirzepatide vs. Alternative Metabolic Compounds
| Research Agent | Targeted Action | Main Research Strength |
|---|---|---|
| Semaglutide | GLP-1 Receptor Agonist | Single-pathway appetite control and highly stable baseline glycemic regulation. |
| Retatrutide | Triple GIP/GLP-1/Glucagon Agonist | Maximum energy expenditure and highly aggressive, direct fat oxidation. |
| HGH Frag 176-191 | Modified GH Fragment | Direct localized lipolysis without altering central appetite pathways. |
| Tirzepatide 10 mg | Dual GIP / GLP-1 Agonist | Ideal balance of excellent glycemic regulation, appetite suppression, and superior lipid clearance. |
Buy SixPex Labs Tirzepatide 10 mg Online
When conducting critical lipid metabolism or weight-loss assays, Peptidesline is your reliable source for batch-certified compounds. Our Tirzepatide is vacuum-sealed and HPLC-verified for 100% integrity.
- Express USA Delivery: Fast shipping to your research facility in 4-7 business days.
- Secure Checkout: Simple payment options via Zelle or Venmo.
- 10% Crypto Discount: Unlock a 10% discount on Tirzepatide 10 mg by paying with Bitcoin or USDT.
- Click here for Payment Options
FAQ
The addition of GIP receptor agonism works synergistically with the GLP-1 pathway to enhance overall metabolic efficiency. This dual mechanism results in significantly improved fat clearance and often fewer severe gastrointestinal side effects during experimental testing. Researchers frequently note better tolerability and more consistent weight-loss models compared to older single-pathway agents.
The 10 mg format provides an extended and reliable supply for assays, ensuring researchers on Peptidesline maintain batch consistency across a much longer experimental timeline. It enables scientists to execute multi-week titration studies without constantly reconstituting new vials. This helps preserve the integrity of the data and avoids unnecessary peptide waste.
Tirzepatide is intelligently designed to support glucose-dependent insulin secretion, meaning it enhances insulin levels only when blood glucose is actively elevated. This smart mechanism prevents the dangerous hypoglycemia often associated with exogenous insulin use. It effectively restores metabolic balance while preserving the test subject's natural pancreatic function.
In rigorous laboratory studies, Tirzepatide demonstrates an extended clearance half-life of approximately 5 days. This prolonged biological activity allows for highly efficient, once-weekly administration protocols in test models. The steady-state concentration provides consistent receptor stimulation, which is vital for gathering accurate longitudinal data.
Tirzepatide is a complex peptide that should be reconstituted gently by slowly dripping bacteriostatic water down the inner wall of the vial. It must be protected from violent physical agitation or shaking to maintain the fragile structural integrity of the dual-chain molecule. Once mixed into a solution, strict refrigeration is required to preserve its maximum potency.
Semaglutide only targets the GLP-1 receptor. Tirzepatide is a dual-agonist that targets both GLP-1 and GIP receptors, resulting in more significant fat loss and improved tolerability.
